Ipca Laboratories is currently trading at Rs. 323.10, up by 0.35 points or 0.11% from its previous closing of Rs. 322.75 on the BSE.
The scrip opened at Rs. 324.90 and has touched a high and low of Rs. 327.50 and Rs. 322.80 respectively. So far 2356 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 375.00 on 10-May-2012 and a 52 week low of Rs. 230.20 on 04-Oct-2011.
Last one week high and low of the scrip stood at Rs. 349.85 and Rs. 320.10 respectively. The current market cap of the company is Rs. 4061.09 crore.
The promoters holding in the company stood at 46.01% while Institutions and Non-Institutions held 31.59% and 22.40% respectively.
Ipca Laboratories has reported results for the quarter and year ended March 31, 2012.
The company’s net profit for the fourth quarter ended March 31, 2012 rose 30.80% to Rs 76.61 crore as compared to Rs 58.57 crore for the quarter ended March 31, 2011. The total income has increased by 17.75% to Rs 564.83 crore for the quarter under review from Rs 479.68 crore for the corresponding quarter of the previous year.
For the year ended March 31, 2012, the company’s net profit jumped by 9.71% to Rs 280.17 crore as compared to Rs 255.37 crore for the previous year. The company’s total income has increased by 23.96% to Rs 2342.29 crore for the year from Rs 1889.61 crore in the previous year.
On consolidated basis, the Group’s net profit stood at Rs 277.06 crore for the year under review as compared to Rs 262.82 crore for the period ago, up by 5.42%. Its total income has increased by 24.24% to Rs 2370.68 crore for the year ended March 31, 2012 from Rs 1908.18 crore in the previous year.
In view of the amalgamation of Tonira Pharma with the company effective April 01, 2011, the financial figures for the current quarter / year are not strictly comparable with that of previous quarter / year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |